Though these are a normal part of human metabolism, they cause significant oxidative stress over time, damaging DNA inside cells and leading to premature aging
Controversy and Diverse Perspectives on BPC-157 While BPC 157 is not officially banned, the FDA's classification has ignited discussions among health experts and supporters of alternative therapies
PubMed pubmed.ncbi.nlm.nih.gov [41] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [42] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [43] The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Adolescents Without Diabetes Mellitus: A Systematic Review and Meta-Analysis PubMed pubmed.ncbi.nlm.nih.gov [44] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point
Uccellatore, A., Genovese, S., Dicembrini, I., Mannucci, E